Baird analysts anticipate Insulet's earnings to grow faster than their annual sales of approx. 20%. DexCom's margins predicted to expand with sales growth over 20% annually before GLP-1s impact. Boston Scientific considered a top-level medtech enterprise by Baird's Rescott.
银休特股票讨论
特斯拉 $特斯拉(TSLA.US)$ : -28.50% 🔻
波音 $波音(BA.US)$ : -28.07% 🔻
MarketAxess $MarketAxess(MKTX.US)$ : -26.75% 🔻
华纳兄弟 $Warner Bros Discovery(WBD.US)$ : -26.36% 🔻
宪章通讯 $特许通讯(CHTR.US)$ : -25.93% 🔻
Lululemon $Lululemon Athletica(LULU.US)$ : -24.48% 🔻
VF 公司 $威富集团(VFC.US)$ : -24.15% 🔻
Humana $哈门那(HUM.US)$ : -23.90% 🔻
胰岛素 $银休特(PODD.US)$ : -23.72% 🔻
派拉蒙 $派拉蒙环球-B(PARA.US)$ : -23.12%...
暂无评论